Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Analytical Overview of Flubromazepam CAS 2647-50-9 and Its Applications in Research

Ноя . 28, 2024 09:04 Back to list

Analytical Overview of Flubromazepam CAS 2647-50-9 and Its Applications in Research



Understanding Flubromazepam A Comprehensive Overview


Flubromazepam is a relatively new member of the benzodiazepine family, characterized by its anxiolytic, sedative, and muscle relaxant properties. It is classified under the International Union of Pure and Applied Chemistry (IUPAC) name 2-(4-bromo-2-fluorophenyl)-1-methyl-1H-benzodiazepine, and it is associated with the CAS number 2647-50-9. This compound has recently gained attention both in the pharmaceutical and recreational drug communities due to its effects and potential for abuse.


Chemical Structure and Properties


Flubromazepam's chemical structure features a benzodiazepine core, which comprises a fusion of a benzene ring and a diazepine ring. The unique addition of a fluorine atom and a bromine atom in its structure differentiates it from other benzodiazepines like diazepam or alprazolam. This particular arrangement is believed to enhance its binding affinity to the GABA-A receptor, leading to its potent psychoactive effects.


Pharmacological Effects

Flubromazepam exhibits a range of pharmacological effects, primarily acting as a central nervous system depressant. Its primary use is to alleviate anxiety and induce sedation. Users may experience a calm, relaxative effect, making it appealing for managing stress-related conditions. Furthermore, it may also have muscle-relaxing properties, contributing to its therapeutic usefulness in various conditions associated with muscle tension.


Despite its therapeutic potential, misuse of flubromazepam can lead to significant side effects. Common side effects include drowsiness, dizziness, impaired coordination, and amnesia, especially with higher doses. Additionally, it has a potential for dependence and withdrawal symptoms similar to those seen with other benzodiazepines, raising concerns in both medical and recreational contexts.


Legal Status and Regulation


The legal status of flubromazepam varies significantly across different countries. In some regions, it might be considered a controlled substance due to its potential for abuse and dependency. For example, it is classified as a Schedule IV controlled substance in several jurisdictions, enforcing strict regulations on its production and distribution.


china cas 2647-50-9 flubromazepam

china cas 2647-50-9 flubromazepam

However, in other areas, flubromazepam might not be explicitly scheduled, which raises concerns regarding its availability and use in the black market. The increased availability combined with limited public knowledge can lead to dangerous usage patterns.


Risks and Considerations


The rise of benzodiazepines like flubromazepam in the recreational drug scene poses several risks. Users often underestimate the potential for addiction and the dangers associated with combining these substances with alcohol or other depressants, which can lead to severe respiratory depression or overdose.


Moreover, the ease of access to flubromazepam through illicit channels has made it a drug of choice for many seeking its euphoric effects. Unfortunately, due to a lack of regulation, users often do not know the purity or dosage of the products they consume, leading to unintended consequences.


Conclusion


Flubromazepam represents a complex interaction of pharmaceutical benefits and potential dangers. As research continues, a better understanding of its effects, risks, and therapeutic applications will be crucial.


For individuals considering its use, whether prescribed or otherwise, it is essential to weigh the therapeutic benefits against potential risks seriously. Education about the drug's properties and responsible usage strategies must be prioritized to mitigate the associated dangers of misuse.


Public health initiatives should focus on increasing awareness and understanding of benzodiazepines while considering the implications of their availability. As society grapples with the challenges of substance use and mental health, the case of flubromazepam underscores the need for a balanced approach to drug regulation and education.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
tt_RUTatar
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu tt_RUTatar